Jonathan Feiber Net Worth & Insider Trades
Jonathan Feiber Adamas Pharmaceuticals Inc
What is Jonathan Feiber's Net Worth?
The current estimated net worth of Adamas Pharmaceuticals Inc's Jonathan Feiber is estimated to be about $477.45M . Jonathan Feiber owns about 4,319,796 units of Adamas Pharmaceuticals Inc common stock. In the last 2 years at Adamas Pharmaceuticals Inc, Jonathan Feiber has sold an estimated value of $4.55M worth.
What is Jonathan Feiber's Past Insider Trading?
Jonathan Feiber's largest purchase order was 1,841,312 units , worth over $4.8M on April 16, 2014. Jonathan Feiber's largest sale order was 119,556 units , worth over $2.15M on June 1, 2015. In total, Jonathan Feiber has made about 12 transactions over 2 years of their time at Adamas Pharmaceuticals Inc. Jonathan Feiber usually trades in September, with the busiest year in 2015. The most recent transaction was a purchase order of 62,977 units , worth over $1.04M on September 16, 2016.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MDV IX LP, Seventh MDV Partners LLC, Ninth MDV Partners LLC, JONATHAN FEIBER, NANCY SCHOENDORF, MDV ENF VII A LP, MDV ENF VII B LP, MDV VII Leaders Fund LP, MDV VII LP
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Jonathan Feiber's' Mailing Address?
- Mailing address is 3000 Sand Hill Road Bldg 1 Menlo Park CA 94025 CA
Adamas Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Neil F. McFarlane | 2020 | $604,167 | $31,300 | $431,300 | $199,000 | $233,220 | $193,954 | $1,692,941 |
| Neil F. McFarlane | 2019 | $182,292 | - | $125,200 | $781,250 | $957,325 | $34,575 | $2,080,642 |
| Vijay Shreedhar, Ph.D. | 2020 | $418,034 | $21,700 | $224,600 | $55,100 | $64,367 | $58,498 | $842,299 |
| Vijay Shreedhar, Ph.D. | 2019 | $252,344 | - | $130,200 | $321,063 | $397,513 | $128,974 | $1,230,094 |
| Christopher B. Prentiss | 2020 | $386,667 | $20,000 | $184,000 | $23,200 | - | $6,912 | $620,779 |
| Christopher B. Prentiss | 2019 | $358,333 | - | $184,000 | $245,188 | $298,980 | $7,140 | $1,093,641 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1328143/000132814321000033/adms2021proxystatement.htm
What are Adamas Pharmaceuticals Inc's Past Insider Trades?
Adamas Pharmaceuticals Inc's most recent insider trade came on June 23, 2021 by Vijay Shreedhar who sold 6,200 units worth $31.98K . In the last 7 years, insiders at Adamas Pharmaceuticals Inc have sold an estimated value of $27.45M and bought an estimated value of $19.72M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are William Ericson, Director, Gregory Went, Chief Executive Officer, and Ivan Lieberburg, Director .
Adamas Pharmaceuticals Inc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||